Metropolitan Life Insurance Company (MetLife)’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-29,994	Closed	-$96K	–	2614
2015 Q4	$96K	Buy	29,994 +2,864	+11%	+$13.8K	﹤0.01%	2504
2015 Q3	$170K	Sell	27,130 -2,923	-10%	-$27.3K	﹤0.01%	2395
2015 Q2	$298K	Buy	+30,053	New	+$263K	﹤0.01%	2126
2015 Q1	–	Sell	-29,258	Closed	-$157K	–	2676
2014 Q4	$157K	Hold	29,258	–	–	﹤0.01%	2541
2014 Q3	$147K	Hold	29,258	–	–	﹤0.01%	2555
2014 Q2	$196K	Buy	+29,258	New	+$186K	﹤0.01%	2524

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NWBO Position: Q1 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q1 2016, closing a stake of 29,994 shares — an estimated $96K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NWBO in Q2 2014 and held it in 6 quarters. The position peaked at $298K in Q2 2015. 74 funds tracked by Wall St. Rank hold NWBO as of Q1 2016.

Metropolitan Life Insurance Company (MetLife) reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q1 2016 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 29,994 Northwest Biotherapeutics, Inc. Common stock shares in Q1 2016, an estimated $96K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 6 quarters.
Metropolitan Life Insurance Company (MetLife)'s Northwest Biotherapeutics, Inc. Common stock position peaked at $298K in Q2 2015.
74 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2016, filed 16 May 2016.